The U.S. Food and Drug Administration has told Moderna it needs more time to assess the company's emergency use authorization (EUA) request for its COVID-19 vaccine for kids 12-17.
The U.S. Food and Drug Administration has told Moderna it needs more time to assess the company's emergency use authorization (EUA) request for its COVID-19 vaccine for kids 12-17.